Amlodipine And Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 31722-446

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 31722-446). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipineandolmesartanmedoxomil10mg20mg30s (Amlodipineandolmesartanmedoxomil10mg20mg30s)

Amlodipine and Olmesartan Medoxomil Tablets, USP 10 mg/20 mg film-coated tablets box label. The label shows the product name, strength, dosage form, NDC 31722-447-30, quantity of 30 tablets, and states it is Rx only. It includes storage instructions, a U.S. contact number, and manufacturer details for Camber Pharmaceuticals, Inc. with manufacturing by Hetero Labs Limited, India.*

FDA Label Image

Amlodipineandolmesartanmedoxomil10mg40mg30s (Amlodipineandolmesartanmedoxomil10mg40mg30s)

Label for Amlodipine and Olmesartan medoxomil Tablets, USP, 10 mg/40 mg film-coated tablets by Camber Pharmaceuticals, Inc. The package contains 30 tablets. Includes storage instructions, dosage note, U.S. contact number, manufacturer details, and barcode.*

FDA Label Image

Amlodipineandolmesartanmedoxomil5mg20mg30s (Amlodipineandolmesartanmedoxomil5mg20mg30s)

Label for Amlodipine and Olmesartan Medoxomil Tablets, USP, film-coated oral tablets with strength 5 mg/20 mg. The label indicates a quantity of 30 tablets and is manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ. It includes storage instructions, contact information, a barcode, and manufacturing details by Hetero Labs Limited in India.*

FDA Label Image

Amlodipineandolmesartanmedoxomil5mg40mg30s (Amlodipineandolmesartanmedoxomil5mg40mg30s)

Label for Amlodipine and Olmesartan Medoxomil Tablets, USP 5 mg/40 mg, film-coated tablets in a package of 30 tablets. Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, with a U.S. contact number provided. Contains storage instructions and dosage information, and states manufacture by Hetero Labs Limited, India.*

FDA Label Image

Amlodipineandolmesartanmedoxomilcamberlogo1 (Amlodipineandolmesartanmedoxomilcamberlogo1)

FDA Label Image

Amlodipineandolmesartanmedoxomilfigure1 (Amlodipineandolmesartanmedoxomilfigure1)

A line graph illustrating the relationship between baseline systolic blood pressure (SBP) and SBP less than 140 mmHg. The graph compares multiple treatment groups, including placebo, 40 mg dose, 10 mg dose of Amlodipine (AML 10 mg), and a combination of Amlodipine and Olmesartan Medoxomil at 10/40 mg. Each group is represented by distinct markers and lines showing changes in SBP across baseline values.*

FDA Label Image

Amlodipineandolmesartanmedoxomilfigure2 (Amlodipineandolmesartanmedoxomilfigure2)

A line graph depicting baseline diastolic blood pressure (DBP) in mmHg on the x-axis versus percentage of patients achieving DBP below 90 mmHg on the y-axis. The graph compares placebo, Amlodipine 10 mg, Olmesartan Medoxomil 40 mg, and a combination of Olmesartan Medoxomil 40 mg with Amlodipine 10 mg.*

FDA Label Image

Amlodipineandolmesartanmedoxomilfigure3 (Amlodipineandolmesartanmedoxomilfigure3)

A line graph depicting the effects of different treatments on systolic blood pressure (SBP) from a baseline SBP range of 140 to 180 mmHg. The graph compares placebo, 10 mg amlodipine, 40 mg olmesartan medoxomil, and a combination of amlodipine 10 mg and olmesartan medoxomil 40 mg, showing SBP changes over this range.*

FDA Label Image

Amlodipineandolmesartanmedoxomilfigure4 (Amlodipineandolmesartanmedoxomilfigure4)

A line graph comparing the change in diastolic blood pressure (DBP) at 50 mmHg across different baseline DBP values (95 to 110 mmHg). The graph includes data series labeled Placebo, BOW40 mg, AML10, and AMLandOlm10/40 mg, illustrating their respective DBP reductions.*

FDA Label Image

Amlodipineandolmesartanmedoxomilstructure1 (Amlodipineandolmesartanmedoxomilstructure1)

Chemical structure diagram showing the molecular structure of the active ingredients Amlodipine and Olmesartan Medoxomil, including annotations indicating the enantiomer form.*

FDA Label Image

Amlodipineandolmesartanmedoxomilstructure2 (Amlodipineandolmesartanmedoxomilstructure2)

Chemical structure diagram of the active ingredient Amlodipine and Olmesartan Medoxomil. The image shows molecular bonds and ring structures characteristic of this pharmaceutical compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.